BeyondSpring Inc. Other Non-Current Liabilities
BeyondSpring Inc. (BYSI) had Other Non-Current Liabilities of $4.42 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-14
- 2026-06-30: Other Liabilities, Noncurrent $4.42M.
- 2026-03-31: Other Liabilities, Noncurrent $4.24M.
- 2025-12-31: Other Liabilities, Noncurrent $3.98M.
- 2025-09-30: Other Liabilities, Noncurrent $3.84M.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2026-06-30 | $4.42M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $4.24M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $3.98M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $3.84M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $3.78M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $3.71M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $3.69M 10-K · filed 2026-03-25 |
| 2024-06-30 | $3.61M 6-K · filed 2024-08-29 |
| 2023-12-31 | $3.71M 10-K · filed 2025-03-27 |
| 2023-06-30 | $3.53M 6-K · filed 2024-02-02 |
| 2022-12-31 | $3.66M 6-K · filed 2024-02-02 |
| 2022-06-30 | $692.00K 6-K · filed 2023-02-28 |
| 2021-12-31 | $709.00K 20-F · filed 2023-04-18 |
| 2021-09-30 | $1.26M 6-K · filed 2021-12-30 |
| 2021-06-30 | $341.00K 6-K · filed 2021-09-10 |
| 2020-12-31 | $0.00 20-F · filed 2022-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |